Novartis melanoma drug combination wins EU green light
July 24, 2015 at 07:29 AM EDT
LONDON, July 24 (Reuters) - European regulators on Friday recommended the use of a combination of Novartis's drugs Tafinlar and Mekinist for treating certain patients with melanoma, boosting prospects for medicines acquired from GlaxoSmithKline.
